-
公开(公告)号:EP4125809A1
公开(公告)日:2023-02-08
申请号:EP21718237.7
申请日:2021-03-25
IPC分类号: A61K9/00 , A61K9/127 , A61K31/41 , A61K31/4178 , A61K31/4184 , A61K31/4245 , A61K47/12 , A61K47/40
-
公开(公告)号:EP3142642A1
公开(公告)日:2017-03-22
申请号:EP15722359.5
申请日:2015-04-08
IPC分类号: A61K9/127 , A61K31/351 , A61K47/40 , A61K47/69
CPC分类号: A61K9/1271 , A61K31/351 , A61K47/40 , A61K47/6951 , Y02A50/411
摘要: Provided are liposomes encapsulating mupirocin, with particular benefit for systemic therapeutically effective delivery. Also provided herein are pharmaceutical compositions including the liposomes and methods of using them. The liposomes include a lipid membrane and an intraliposomal compartment, the intraliposomal compartment encapsulating mupirocin, at least one cyclodextrin compound and a pH dependent ionizable anion, e.g. acetate.
摘要翻译: 提供包封莫匹罗星的脂质体,特别有益于全身治疗有效递送。 本文还提供包含脂质体的药物组合物及其使用方法。 脂质体包括脂质膜和脂质体内隔室,包封莫匹罗星的脂质体内区域,至少一种环糊精化合物和pH依赖性可电离阴离子,例如, 醋酸。
-
公开(公告)号:EP4037662A1
公开(公告)日:2022-08-10
申请号:EP20792754.2
申请日:2020-10-01
发明人: BARENHOLZ, Yechezkel , CERN, Ahuva
-
公开(公告)号:EP4013390A1
公开(公告)日:2022-06-22
申请号:EP20760938.9
申请日:2020-08-12
发明人: BARENHOLZ, Yechezkel , CERN, Ahuva
IPC分类号: A61K9/127 , A61K31/485 , A61K31/5377 , A61K9/06 , A61K47/34 , A61K9/00
-
公开(公告)号:EP4221683A1
公开(公告)日:2023-08-09
申请号:EP21791043.9
申请日:2021-09-30
发明人: BARENHOLZ, Yechezkel , CERN, Ahuva
-
公开(公告)号:EP3142642B1
公开(公告)日:2018-08-29
申请号:EP15722359.5
申请日:2015-04-08
IPC分类号: A61K9/127 , A61K31/351 , A61K47/40 , A61K47/69
CPC分类号: A61K9/1271 , A61K31/351 , A61K47/40 , A61K47/6951 , Y02A50/411
摘要: Provided are liposomes encapsulating mupirocin, with particular benefit for systemic therapeutically effective delivery. Also provided herein are pharmaceutical compositions including the liposomes and methods of using them. The liposomes include a lipid membrane and an intraliposomal compartment, the intraliposomal compartment encapsulating mupirocin, at least one cyclodextrin compound and a pH dependent ionizable anion, e.g. acetate.
-
-
-
-
-